162 related articles for article (PubMed ID: 34843875)
1. Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.
Yuferov V; Butelman ER; Randesi M; Ott J; Kreek MJ
Neurosci Lett; 2022 Jan; 768():136364. PubMed ID: 34843875
[TBL] [Abstract][Full Text] [Related]
2. Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.
Yuferov V; Fussell D; LaForge KS; Nielsen DA; Gordon D; Ho A; Leal SM; Ott J; Kreek MJ
Pharmacogenetics; 2004 Dec; 14(12):793-804. PubMed ID: 15608558
[TBL] [Abstract][Full Text] [Related]
3. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
[TBL] [Abstract][Full Text] [Related]
4. An analysis of genetic association in opioid dependence susceptibility.
Nagaya D; Zahari Z; Saleem M; Yahaya BH; Tan SC; Yusoff NM
J Clin Pharm Ther; 2018 Feb; 43(1):80-86. PubMed ID: 28656735
[TBL] [Abstract][Full Text] [Related]
5. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.
Zhang H; Kranzler HR; Yang BZ; Luo X; Gelernter J
Mol Psychiatry; 2008 May; 13(5):531-43. PubMed ID: 17622222
[TBL] [Abstract][Full Text] [Related]
6. Effect of PDYN and OPRK1 polymorphisms on the risk of alcohol use disorder and the intensity of depressive symptoms.
Özkan-Kotiloğlu S; Kaya-Akyüzlü D; Yurdakul R; Yıldırım MA; Özgür-İlhan İ
Alcohol Alcohol; 2023 Jul; 58(4):404-414. PubMed ID: 37177778
[TBL] [Abstract][Full Text] [Related]
7. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
Kumar D; Chakraborty J; Das S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
[TBL] [Abstract][Full Text] [Related]
8. Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.
Clarke TK; Ambrose-Lanci L; Ferraro TN; Berrettini WH; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Lohoff FW
Genes Brain Behav; 2012 Jun; 11(4):415-23. PubMed ID: 22443215
[TBL] [Abstract][Full Text] [Related]
9. Association of
Özkan-Kotiloğlu S; Kaya-Akyüzlü D; Yalçın-Şahiner Ş; Ayaz N
Pharmacogenomics; 2023 Apr; 24(6):325-334. PubMed ID: 37166316
[No Abstract] [Full Text] [Related]
10. Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.
Crist RC; Ambrose-Lanci LM; Vaswani M; Clarke TK; Zeng A; Yuan C; Ferraro TN; Hakonarson H; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Doyle GA; Lohoff FW; Berrettini WH
Drug Alcohol Depend; 2013 Jan; 127(1-3):122-8. PubMed ID: 22795689
[TBL] [Abstract][Full Text] [Related]
11. Case-control association study of WLS variants in opioid and cocaine addicted populations.
Crist RC; Ambrose-Lanci LM; Zeng A; Yuan C; Kampman KM; Pettinati HM; Oslin DW; O'Brien CP; Ferraro TN; Doyle GA; Lohoff FW; Berrettini WH
Psychiatry Res; 2013 Jun; 208(1):62-6. PubMed ID: 23566366
[TBL] [Abstract][Full Text] [Related]
12. Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use.
Yuferov V; Randesi M; Butelman ER; van den Brink W; Blanken P; van Ree JM; Ott J; Kreek MJ
Neurosci Lett; 2019 Jun; 704():100-105. PubMed ID: 30936032
[TBL] [Abstract][Full Text] [Related]
13. Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction.
Gerra G; Leonardi C; Cortese E; D'Amore A; Lucchini A; Strepparola G; Serio G; Farina G; Magnelli F; Zaimovic A; Mancini A; Turci M; Manfredini M; Donnini C
Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):771-5. PubMed ID: 17373729
[TBL] [Abstract][Full Text] [Related]
14. Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states.
Karpyak VM; Winham SJ; Preuss UW; Zill P; Cunningham JM; Walker DL; Lewis KA; Geske JR; Colby CL; Abulseoud OA; Hall-Flavin DK; Loukianova LL; Schneekloth TD; Frye MA; Bazov I; Heit JA; Bakalkin G; Mrazek DA; Biernacka JM
Int J Neuropsychopharmacol; 2013 Jun; 16(5):975-85. PubMed ID: 23101464
[TBL] [Abstract][Full Text] [Related]
15. A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain.
Yuferov V; Ji F; Nielsen DA; Levran O; Ho A; Morgello S; Shi R; Ott J; Kreek MJ
Neuropsychopharmacology; 2009 Apr; 34(5):1185-97. PubMed ID: 18923396
[TBL] [Abstract][Full Text] [Related]
16. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
Zhang Q; Shi M; Tang H; Zhong H; Lu X
Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
[No Abstract] [Full Text] [Related]
17. A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk.
Xu K; Seo D; Hodgkinson C; Hu Y; Goldman D; Sinha R
Transl Psychiatry; 2013 Aug; 3(8):e292. PubMed ID: 23962922
[TBL] [Abstract][Full Text] [Related]
18. Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence.
Yuanyuan J; Rui S; Hua T; Jingjing C; Cuola D; Yuhui S; Shuguang W
Neurosci Lett; 2018 Oct; 685():75-82. PubMed ID: 30138645
[TBL] [Abstract][Full Text] [Related]
19. The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.
Clarke TK; Weiss AR; Ferarro TN; Kampman KM; Dackis CA; Pettinati HM; O'brien CP; Oslin DW; Lohoff FW; Berrettini WH
Ann Hum Genet; 2014 Jan; 78(1):33-9. PubMed ID: 24359476
[TBL] [Abstract][Full Text] [Related]
20. Association of the kappa-opioid system with alcohol dependence.
Xuei X; Dick D; Flury-Wetherill L; Tian HJ; Agrawal A; Bierut L; Goate A; Bucholz K; Schuckit M; Nurnberger J; Tischfield J; Kuperman S; Porjesz B; Begleiter H; Foroud T; Edenberg HJ
Mol Psychiatry; 2006 Nov; 11(11):1016-24. PubMed ID: 16924269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
